CLINICAL_TRIALS
trial_result
· 2022-05-17
Clinical Trial Update: Helicobacter Eradication Aspirin Trial [Phase 4]
Summary
Phase 4 clinical trial update on Helicobacter eradication in the context of gastrointestinal ulcer hemorrhage and H. pylori infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Nottingham | Conditions: Gastrointestinal Ulcer Haemorrhage, Bacterial Infection Due to Helicobacter Pylori (H. Pylori) | Phase 4 | Status: COMPLETED